| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/11/2000 | US6087144 Mammalian enzymatic protein receptor; for the activation of cell differentiation and propagation; for screening modulators or receptor activity |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087130 Antibody substances that bind to ICAM-related protein |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6087117 Murine immunoglobulin which binds to mamalian tumor protein; for genetic testing of cancer senesitivity, diagnosis, and treatment |
| 07/11/2000 | US6087113 Recovering mammalian bone marrow aggregations from mixture; incubation of aggregations with preferential immunoglobulin, recovering immunoglobulin bound aggregations |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6087106 Nucleic acids conferring and inducible resistance to glycopeptides particularly in gram-positive bacteria |
| 07/11/2000 | US6087105 Nucleotide sequences coding a protein associated with adherence and infection of bacterial parasite; for detection of modulators of bacterial adhesion |
| 07/11/2000 | US6086896 Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins |
| 07/11/2000 | US6086879 Antibody to the syncytiotrophoblast antigen R80K and use thereof |
| 07/11/2000 | US6086878 By administering a gastrointestinal neuromodulator antibody, such as antibodies to bombesin, cholecystokinin, gastrin, somatostatin, and neuropeptide y; for egg or milk-producing animals |
| 07/11/2000 | US6086877 Therapeutic agent for rheumatic disease |
| 07/11/2000 | US6086876 Suppressing interleukin-12 (il-12) production in a human by administering a ligand that binds the complement receptor protein cd46, the ligand suspended in a carrier and binding suppresses il-12 production; treating autoimmune diseases |
| 07/11/2000 | US6086875 Receptor specific transepithelial transport of immunogens |
| 07/11/2000 | US6086873 Irradiating an antibody with ultraviolet light to expose a reactive sulfhydryl of the antibody without changing its biological function, administering to a host to generate a greater immune response than against the native antibody |
| 07/11/2000 | US6086867 By contacting the cell with a soluble polypeptide comprising the amino acid sequence of the extracellular domain of the transforming growth factor-beta (tgf-b) type iii receptor protein or mammalian dna encoding it |
| 07/11/2000 | CA2082948C Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 07/11/2000 | CA2012740C A monoclonal antibody recognizing c-terminus of anp |
| 07/11/2000 | CA1341050C Neurite growth regulatory factors |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039589A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039320A1 Transfectacons comprising calcium phosphate and a nucleic acid |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039297A2 Il-1 related polypeptides |
| 07/06/2000 | WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039159A1 Superantigens |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039154A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | WO2000039147A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 07/06/2000 | WO2000039145A1 Targeted gene transfer using g protein coupled receptors |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038714A1 The prevention and treatment of retinal ischemia and edema |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
| 07/06/2000 | WO2000021988A3 Human ankyrin family protein |
| 07/06/2000 | WO2000020020A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | WO1999063087A9 G-protein coupled receptor, named 2871 receptor |
| 07/06/2000 | WO1999061600A9 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/06/2000 | WO1999054461A3 Human nucleic acid sequences of endometrium tumour tissue |
| 07/06/2000 | WO1999054448A3 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue |
| 07/06/2000 | WO1999054447A3 Human nucleic acid sequences of bladder tumour tissue |
| 07/06/2000 | WO1999053040A3 Human nucleic acid sequences from ovarian tumour tissue |
| 07/06/2000 | WO1999051727A3 Human nucleic acid sequences of normal ovary tissue |
| 07/06/2000 | WO1999047655A3 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 07/06/2000 | WO1999047535A9 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 07/06/2000 | WO1999046375A3 Human nucleic acid sequences from prostate tissue |
| 07/06/2000 | WO1999046374A3 Human nucleic acid sequences from prostate tumour tissue |
| 07/06/2000 | WO1999040119A9 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 07/06/2000 | CA2363999A1 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2357873A1 The prevention and treatment of retinal ischemia and edema |
| 07/06/2000 | CA2357036A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | CA2356755A1 Superantigens |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356608A1 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides abd uses thereof |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2355227A1 Targeted gene transfer using g protein coupled receptors |
| 07/06/2000 | CA2355096A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | CA2354562A1 Transfectacons comprising calcium phosphate and a nucleic acid |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354027A1 Il-1 related polypeptides |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016866A1 NOVEL COMPOUND 2-AMINO-3-[2-(a)-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1016671A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| 07/05/2000 | EP1015886A1 Detection of measles virus-specific antibodies |
| 07/05/2000 | EP1015625A2 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
| 07/05/2000 | EP1015624A2 P53-induced apoptosis |
| 07/05/2000 | EP1015616A2 Intrabody-mediated control of immune reactions |
| 07/05/2000 | EP1015615A1 Targeted gene transfer using g protein coupled receptors |
| 07/05/2000 | EP1015610A2 Medicament for treating a manifested lyme disease |
| 07/05/2000 | EP1015607A1 Dna encoding a ras carboxyl-terminal processing protein |